Déborah Bauer - Concepedia

Author

Déborah Bauer

Also Known As

Bauer, Deborah, D Bauer, D. Bauer, Deborah Bauer, Deborah E. Bauer, Deborah E. Bauer, Deborah Elaine Bauer, Déborah Bauer

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Sanofi (United States)Regeneron (United States)Sanofi (France)Icahn School of Medicine at Mount Sinai University of Alabama at Birmingham

About

Déborah Bauer is an author at Sanofi (United States) specializing in medicine, psychiatry, and schizophrenia.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	868
2	Health Sciences	2	2	141
3	Social Sciences	2	2	182
4	Natural Sciences	1	1	112
5	Public Health	1	1	49

Déborah Bauer

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts Surya P. Bhatt, Klaus F. Rabe, Nicola A. Hanania, New England Journal of Medicine	2023	407
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial Patrick Vermersch, Anna Członkowska, Luigi ME Grimaldi, Multiple Sclerosis Journal	2013	348
Placebo-Controlled Evaluation of Four Novel Compounds for the Treatment of Schizophrenia and Schizoaffective Disorder Herbert Y. Meltzer, Lisa A. Arvanitis, Déborah Bauer, American Journal of Psychiatry	2004	331
Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial Gerd R Burmester, Yong Lin, Rahul Patel, Annals of the Rheumatic Diseases	2016	306
Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial Aaron Miller, Jerry S. Wolinsky, Ludwig Kappos, The Lancet Neurology Oral TeriflunomideNeurological DisorderSymptomatic TreatmentClinical TrialsNeurology	2014	295
Sarilumab and Nonbiologic Disease‐Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors Roy Fleischmann, Janet van Adelsberg, Yong Lin, Arthritis & Rheumatology	2016	201
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation Surya P. Bhatt, Klaus F. Rabe, Nicola A. Hanania, New England Journal of Medicine	2024	201
Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis Amit Bar‐Or, Mark Freedman, Marcelo Kremenchutzky, Neurology	2013	121
Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophrenia Déborah Bauer, Vahram Haroutunian, James H. Meador‐Woodruff, Schizophrenia Research NeuropsychologyAlzheimer's DiseasePsychiatryAbnormal GlycosylationElderly Patients	2009	120
The glutamate transporter, GLAST, participates in a macromolecular complex that supports glutamate metabolism Déborah Bauer, Joshua G. Jackson, Elizabeth N. Genda, Neurochemistry International Glutamate TransporterMolecular NeuroscienceMolecular PhysiologyBiochemistrySignal Transduction	2012	112

Page 1